Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 1361 results
Author [ Title(Desc)] Year
Filters: First Letter Of Last Name is L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Everitt MD, Wilkinson JD, Shi L, et al. "Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry." Prog. Pediatr. Cardiol.. 2019;53:1-10.
Everitt MD, Wilkinson JD, Shi L, et al. "Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry." Prog. Pediatr. Cardiol.. 2019;53:1-10.
Burstein D, Maude S, Grupp S, Griffis H, Rossano J, Lin K. "Cardiac Profile of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Children: a Single Institution Experience." Biol Blood Marrow Transplant. 2018.
Mathieu I, Wallis K, Japa I, et al. "Caregiver Strengths, Attitudes, and Concerns About Reading and Child Development in the Dominican Republic." Glob Pediatr Health. 2020;7:2333794X20942661.
Williamson AA, Leichman ES, Walters RM, Mindell JA. "Caregiver-perceived sleep outcomes in toddlers sleeping in cribs versus beds." Sleep Med.. 2019;54:16-21.
Magrini D, Li SC, Bhise V, Weiss PF, Moorthy LN. "Case 1: Alopecia in a Healthy 9-year-old Girl." Pediatr Rev. 2015;36(11):503-5.
Scheetz MH, Lodise TP, Downes KJ, Drusano G, Neely M. "The case for precision dosing: medical conservatism does not justify inaction." J Antimicrob Chemother. 2021.
Lindell RB, Wolf MS, Alcamo AM, et al. "Case Report: Immune Dysregulation Due to Reactivation After Allogeneic Hematopoietic Cell Transplant." Front Pediatr. 2021;9:719679.
Mitchell HK, Mokomane M, Leeme T, et al. "Causes of Pediatric Meningitis in Botswana: Results From a 16-Year National Meningitis Audit." Pediatr. Infect. Dis. J.. 2019.
Huang BJ, Smith J, Wang J, et al. "CBFB-MYH11 Fusion Transcripts Distinguish Acute Myeloid Leukemias with Distinct Molecular Landscapes and Outcomes." Blood Adv. 2021.
Huang BJ, Smith J, Wang J, et al. "CBFB-MYH11 Fusion Transcripts Distinguish Acute Myeloid Leukemias with Distinct Molecular Landscapes and Outcomes." Blood Adv. 2021.
Lamble AJ, Brodersen LEidenschin, Alonzo TA, et al. "CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J Clin Oncol. 2021:JCO2101595.
Lamble AJ, Brodersen LEidenschin, Alonzo TA, et al. "CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J Clin Oncol. 2021:JCO2101595.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Pollard JA, Loken MR, Gerbing RB, et al. "CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531." J. Clin. Oncol.. 2016;34(7):747-55.
Lamba JK, Chauhan L, Shin M, et al. "CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531." J. Clin. Oncol.. 2017:JCO2016712513.
Lamba JK, Chauhan L, Shin M, et al. "CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531." J. Clin. Oncol.. 2017:JCO2016712513.
Lamba JK, Voigt AP, Chauhan L, et al. "CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients." Leuk. Lymphoma. 2018:1-4.
Lamba JK, Voigt AP, Chauhan L, et al. "CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients." Leuk. Lymphoma. 2018:1-4.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
O'Connor MJ, Zhang X, Griffis H, et al. "Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort." Pediatr Cardiol. 2021.

Pages